| Kinpeygo 4 mg modified-release hard capsules EU/1/22/1657/001 |
Budesonide micronised |
Stada Arzneimittel AG |
— |
| Kinzalkomb 40 mg/12.5 mg tablets EU/1/02/214/1-5 |
Telmisartan, Hydrochlorothiazide |
Bayer AG |
— |
| Kinzalkomb 80 mg/12.5 mg tablets EU/1/02/214/006-010 |
Telmisartan, Hydrochlorothiazide |
Bayer AG |
— |
| Kinzalkomb 80 mg/25 mg tablets EU/1/02/214/11-15 |
Hydrochlorothiazide, Telmisartan |
Bayer AG |
— |
| Kinzalmono 20 mg tablets EU/1/98/091/009-012 |
Telmisartan |
Bayer AG |
— |
| Kinzalmono 40 mg tablets EU/1/98/091/001-004 |
Telmisartan |
Bayer AG |
— |
| Kinzalmono 80 mg tablets EU/1/98/091/005-008 |
Telmisartan |
Bayer AG |
— |
| Kiovig 100 mg/ml solution for infusion EU/1/05/329/001-006 |
Human normal immunoglobulin |
Baxter AG |
— |
| Kirsty EU/1/20/1506/001-007 |
Insulin aspart |
Biosimilar Collaborations Ireland Limited |
— |
| Kisplyx 10 mg hard capsules EU/1/16/1128/002 |
Lenvatinib mesilate |
Eisai GmbH |
— |
| Kisplyx 4 mg hard capsules EU/1/16/1128/001 |
Lenvatinib mesilate |
Eisai GmbH |
— |
| Kisqali 200 mg film-coated tablets EU/1/17/1221/001-012 |
Ribociclib |
Novartis Europharm Limited |
— |
| Kisunla 350 mg concentrate for solution for infusion EU/1/25/1926/001-002 |
Donanemab |
Eli Lilly Nederland B.V. |
— |
| KIVEXA EU/1/04/298/1-2 |
Abacavir sulfate, Lamivudine |
ViiV Healthcare BV |
— |
| Klisyri 10 mg/g ointment EU/1/21/1558/001 |
Tirbanibulin |
Almirall, S.A. |
— |
| Kogenate Bayer EU/1/00/143/002 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/003 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/005 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/006 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/012-013 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Kogenate Bayer EU/1/00/143/10-11 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| KOGENATE Bayer EU/1/00/143/001 |
Octocog alfa, R-dna (baby hamster kidney expression system) |
Bayer AG |
— |
| KOGENATE BAYER EU/1/00/143/004 |
Octocog alfa |
Bayer Schering Pharma AG |
— |
| Komboglyze 2.5 mg/1000 mg film-coated tablets EU/1/11/731/007-012 |
Metformin Hydrochloride, Saxagliptin |
AstraZeneca AB |
— |
| Komboglyze 2.5 mg/850 mg film-coated tablets EU/1/11/731/001-006 |
Saxagliptin, Metformin Hydrochloride |
AstraZeneca AB |
— |
| Kopen 250mg Tablets PA1418/014/003 |
Phenoxymethylpenicillin potassium |
Athlone Pharmaceuticals Limited |
Marketed |
| Kopen Sugar Free 125 mg/5 ml Powder for Oral Solution PA1418/014/001 |
Phenoxymethylpenicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Kopen Sugar Free 250 mg/5 ml Powder for Oral Solution PA1418/014/002 |
Phenoxymethylpenicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Korjuny 10 micrograms concentrate for solution for infusion EU/1/24/1826/001 |
Catumaxomab |
Atnahs Pharma Netherlands B.V. |
— |
| Korjuny 50 micrograms concentrate for solution for infusion EU/1/24/1826/002 |
Catumaxomab |
Atnahs Pharma Netherlands B.V. |
— |
| Koselugo 10 mg hard capsules EU/1/21/1552/001 |
Selumetinib Sulfate |
AstraZeneca AB |
— |
| Koselugo 25 mg hard capsules EU/1/21/1552/002 |
Selumetinib Sulfate |
AstraZeneca AB |
— |
| Kostaive powder for dispersion for injection. COVID-19 sa-mRNA Vaccine EU/1/24/1873/001 |
Zapomeran |
Arcturus Therapeutics Europe B.V. |
— |
| Kovaltry 1000 IU powder and solvent for solution for injection EU/1/15/1076/006 |
Octocog alfa |
Bayer Pharma AG |
— |
| Kovaltry 2000 IU powder and solvent for solution for injection EU/1/15/1076/008 |
Octocog alfa |
Bayer Pharma AG |
— |
| Kovaltry 250 IU powder and solvent for solution for injection EU/1/15/1076/002 |
Octocog alfa |
Bayer AG |
— |
| Kovaltry 3000 IU powder and solvent for solution for injection EU/1/15/1076/010 |
Octocog alfa |
Bayer Pharma AG |
— |
| Kovaltry 500 IU powder and solvent for solution for injection EU/1/15/1076/004 |
Octocog alfa |
Bayer Pharma AG |
— |
| KRAZATI 200 mg film-coated tablets EU/1/23/1744/001-002 |
Adagrasib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Kuvan 100 mg powder for oral solution EU/1/08/481/004 |
Sapropterin hydrochloride |
Biomarin International Limited |
— |
| Kuvan 100 mg soluble tablets EU/1/08/481/1-3 |
Sapropterin dihydrochloride |
Biomarin International Limited |
— |
| Kuvan 500 mg powder for oral solution EU/1/08/481/005 |
Sapropterin hydrochloride |
Biomarin International Limited |
— |
| Kymriah 1.2 × 106 – 6 × 108 cells dispersion for infusion EU/1/18/1297/001 |
AUTOGLAS T CELLS TRANSDUCED WITH LENTIVIRAL VECTOR CONTAINING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST CD1 |
Novartis Europharm Limited |
— |
| Kyntheum 210 mg solution for injection in pre-filled syringe EU/1/16/1155/001 |
Brodalumab |
LEO Pharma A/S |
— |
| Kyprolis 60 mg powder for solution for infusion EU/1/15/1060/001 |
Carfilzomib |
Amgen Europe B.V., |
— |
| Lacosamide Accord 10 mg/ml solution for infusion EU/1/17/1230/026-027 |
Lacosamide |
Accord Healthcare S.L.U. |
— |
| Lacosamide Accord 100 mg film coated tablets EU/1/17/1230/005-008 |
Lacosamide |
Accord Healthcare S.L.U. |
— |
| Lacosamide Accord 150 mg film coated tablets EU/1/17/1230/009-012 |
Lacosamide |
Accord Healthcare S.L.U. |
— |
| Lacosamide Accord 200 mg film coated tablets EU/1/17/1230/013-016 |
Lacosamide |
Accord Healthcare S.L.U. |
— |
| Lacosamide Accord 50 mg film coated tablets EU/1/17/1230/001-004 |
Lacosamide |
Accord Healthcare S.L.U. |
— |